Xeris Biopharma Holdings Inc
NASDAQ:XERS

Watchlist Manager
Xeris Biopharma Holdings Inc Logo
Xeris Biopharma Holdings Inc
NASDAQ:XERS
Watchlist
Price: 3.05 USD -3.17% Market Closed
Market Cap: 454.5m USD
Have any thoughts about
Xeris Biopharma Holdings Inc?
Write Note

Xeris Biopharma Holdings Inc
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Xeris Biopharma Holdings Inc
Net Income Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
Xeris Biopharma Holdings Inc
NASDAQ:XERS
Net Income
-$59.6m
CAGR 3-Years
11%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Net Income
$14.7B
CAGR 3-Years
-6%
CAGR 5-Years
1%
CAGR 10-Years
-2%
Bristol-Myers Squibb Co
NYSE:BMY
Net Income
-$7.2B
CAGR 3-Years
-10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
Net Income
-$2.6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Net Income
$12.2B
CAGR 3-Years
27%
CAGR 5-Years
6%
CAGR 10-Years
8%
Eli Lilly and Co
NYSE:LLY
Net Income
$8.4B
CAGR 3-Years
12%
CAGR 5-Years
1%
CAGR 10-Years
12%

See Also

What is Xeris Biopharma Holdings Inc's Net Income?
Net Income
-59.6m USD

Based on the financial report for Jun 30, 2024, Xeris Biopharma Holdings Inc's Net Income amounts to -59.6m USD.

What is Xeris Biopharma Holdings Inc's Net Income growth rate?
Net Income CAGR 5Y
9%

Over the last year, the Net Income growth was 17%. The average annual Net Income growth rates for Xeris Biopharma Holdings Inc have been 11% over the past three years , 9% over the past five years .

Back to Top